Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 99 articles:
HTML format
Text format



Single Articles


    September 2017
  1. PACHNIA D, Drop B, Dworzanska A, Kliszczewska E, et al
    Transforming Growth Factor-beta, Interleukin-10, and Serological Markers in EBV-associated Gastric Carcinoma.
    Anticancer Res. 2017;37:4853-4858.
    PubMed     Text format     Abstract available


    August 2017
  2. YIN J, Song JN, Bai ZG, Cai J, et al
    Gastric Cancer Mortality Trends in China (2006-2013) Reveal Increasing Mortality in Young Subjects.
    Anticancer Res. 2017;37:4671-4679.
    PubMed     Text format     Abstract available


  3. DONG W, Li B, Wang J, Song Y, et al
    Exploration of the Radiotherapeutic Clinical Target Volume Delineation for Gastric Cancer from Lymph Node Metastases.
    Anticancer Res. 2017;37:4629-4634.
    PubMed     Text format     Abstract available


  4. HUO X, Xiao X, Zhang S, Zhou D, et al
    Association of Intron Microsatellite Instability and Exon Mutational Profile of TP53 in Human Gastric Cancers.
    Anticancer Res. 2017;37:4507-4514.
    PubMed     Text format     Abstract available


  5. YIN J, Cui Y, Li L, Ji J, et al
    Overexpression of EPHB4 Is Associated with Poor Survival of Patients with Gastric Cancer.
    Anticancer Res. 2017;37:4489-4497.
    PubMed     Text format     Abstract available


  6. LI L, Cui Y, Ji JF, Jiang WG, et al
    Clinical Correlation Between WISP2 and beta-Catenin in Gastric Cancer.
    Anticancer Res. 2017;37:4469-4473.
    PubMed     Text format     Abstract available


  7. JIANG A, Zhao H, Liu X, Yu M, et al
    Comparison of Different Muscle-Relaxant Anesthetics on Growth, Migration and Invasion of Gastric Cancer Cells.
    Anticancer Res. 2017;37:4371-4378.
    PubMed     Text format     Abstract available


  8. MIMATSU K, Fukino N, Ogasawara Y, Saino Y, et al
    Utility of Inflammatory Marker- and Nutritional Status-based Prognostic Factors for Predicting the Prognosis of Stage IV Gastric Cancer Patients Undergoing Non-curative Surgery.
    Anticancer Res. 2017;37:4215-4222.
    PubMed     Text format     Abstract available


  9. VIRGILIO E, Giarnieri E, Giovagnoli MR, Montagnini M, et al
    Early Gastric Cancer Exfoliating into Gastric Lavage (GL1 EGC) Shows a More Aggressive Behavior and Poorer Survival Compared to the Non-Exfoliative Counterpart (GL0 EGC).
    Anticancer Res. 2017;37:4199-4203.
    PubMed     Text format     Abstract available


  10. LIU L, Zhao H, Sheng L, Yang P, et al
    Collision of Lymphoepithelioma-like Carcinoma with Diffuse Large B-cell Lymphoma of the Stomach: A Case Report.
    Anticancer Res. 2017;37:4569-4573.
    PubMed     Text format     Abstract available


  11. GONG Z, Mu Y, Chen J, Chu H, et al
    Expression and Significance of Cyclophilin J in Primary Gastric Adenocarcinoma.
    Anticancer Res. 2017;37:4475-4481.
    PubMed     Text format     Abstract available


    July 2017
  12. TAKIMOTO R, Kamigaki T, Okada S, Matsuda E, et al
    Efficacy of Adoptive Immune-cell Therapy in Patients with Advanced Gastric Cancer: A Retrospective Study.
    Anticancer Res. 2017;37:3947-3954.
    PubMed     Text format     Abstract available


  13. SATAKE H, Kondo M, Mizumoto M, Kotake T, et al
    Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer.
    Anticancer Res. 2017;37:3703-3710.
    PubMed     Text format     Abstract available


  14. KAITO A, Kinoshita T, Tokunaga M, Sunagawa H, et al
    Prognostic Factors and Recurrence Pattern of Far-advanced Gastric Cancer with Pathologically-positive Para-aortic Lymph Nodes.
    Anticancer Res. 2017;37:3685-3692.
    PubMed     Text format     Abstract available


  15. KASHIHARA H, Shimada M, Yoshikawa K, Higashijima J, et al
    Correlation Between Thrombospondin-1 Expression in Non-cancer Tissue and Gastric Carcinogenesis.
    Anticancer Res. 2017;37:3547-3552.
    PubMed     Text format     Abstract available


    June 2017
  16. MOON JH, Fujiwara Y, Hirao M, Imamura H, et al
    Randomized Controlled Trial of Adjuvant Chemotherapy with Fluoropyrimidines Versus Surgery-alone for Gastric Cancer.
    Anticancer Res. 2017;37:3061-3067.
    PubMed     Text format     Abstract available


  17. TOKUMOTO M, Tanaka H, Tauchi Y, Tamura T, et al
    Immunoregulatory Function of Lymphatic Endothelial Cells in Tumor-draining Lymph Nodes of Human Gastric Cancer.
    Anticancer Res. 2017;37:2875-2883.
    PubMed     Text format     Abstract available


  18. VIRGILIO E, Proietti A, D'Urso R, Cardelli P, et al
    Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability.
    Anticancer Res. 2017;37:2817-2821.
    PubMed     Text format     Abstract available


  19. ARATANI K, Komatsu S, Ichikawa D, Ohashi T, et al
    Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Anticancer Res. 2017;37:3129-3135.
    PubMed     Text format     Abstract available


    May 2017
  20. KANAZAWA Y, Fujita I, Kakinuma D, Arai H, et al
    Initial Experience with Nab-Paclitaxel for Patients with Advanced Gastric Cancer: Safety and Efficacy.
    Anticancer Res. 2017;37:2715-2720.
    PubMed     Text format     Abstract available


  21. INADOMI K, Kusaba H, Matsushita Y, Tanaka R, et al
    Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric Cancer.
    Anticancer Res. 2017;37:2663-2671.
    PubMed     Text format     Abstract available


  22. DA SILVA OLIVEIRA KC, Bona AB, DA Silva FJ, Pinheiro TM, et al
    Expression of hsa-miR-9 and MYC Copy Number Variation in Hereditary Diffuse Gastric Cancer.
    Anticancer Res. 2017;37:2401-2406.
    PubMed     Text format     Abstract available


    April 2017
  23. TAHARA T, Tahara S, Horiguchi N, Kawamura T, et al
    Telomere Length in Leukocyte DNA in Gastric Cancer Patients and its Association with Clinicopathological Features and Prognosis.
    Anticancer Res. 2017;37:1997-2001.
    PubMed     Text format     Abstract available


  24. KUNIZAKI M, Fukuda A, Wakata K, Tominaga T, et al
    Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Anticancer Res. 2017;37:1979-1984.
    PubMed     Text format     Abstract available


    March 2017
  25. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Efficacy of Conversion Surgery Following S-1 plus Cisplatin or Oxaliplatin Chemotherapy for Unresectable Gastric Cancer.
    Anticancer Res. 2017;37:1343-1347.
    PubMed     Text format     Abstract available


  26. MITA K, Ito H, Ota E, Takahashi K, et al
    Adjuvant Chemotherapy with S-1 plus Cisplatin for Patients with Stage III Gastric Cancer After Curative Resection.
    Anticancer Res. 2017;37:1329-1333.
    PubMed     Text format     Abstract available


  27. AHN SY, Kim J, Kim MA, Choi J, et al
    Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.
    Anticancer Res. 2017;37:1127-1138.
    PubMed     Text format     Abstract available


  28. DAI X, Liu D, Liu M, Zhang X, et al
    Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model.
    Anticancer Res. 2017;37:979-986.
    PubMed     Text format     Abstract available


    February 2017
  29. SATOH T, Kaira K, Takahashi K, Takahashi N, et al
    Prognostic Significance of the Expression of CD98 (4F2hc) in Gastric Cancer.
    Anticancer Res. 2017;37:631-636.
    PubMed     Text format     Abstract available


  30. BAUER G
    Central Signaling Elements of Intercellular Reactive Oxygen/Nitrogen Species-dependent Induction of Apoptosis in Malignant Cells.
    Anticancer Res. 2017;37:499-513.
    PubMed     Text format     Abstract available


  31. BACKMAN S, Norlen O, Eriksson B, Skogseid B, et al
    Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
    Anticancer Res. 2017;37:705-712.
    PubMed     Text format     Abstract available


  32. PROUET P, Giri S, Wiedower E, Fintel A, et al
    Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality.
    Anticancer Res. 2017;37:813-817.
    PubMed     Text format     Abstract available


    January 2017
  33. OGATA K, Yanai M, Kuriyama K, Suzuki M, et al
    Double Endoscopic Intraluminal Operation (DEILO) for Early Gastric Cancer: Outcome of Novel Procedure for Endoscopic Submucosal Dissection.
    Anticancer Res. 2017;37:343-347.
    PubMed     Text format     Abstract available


  34. SUGIYAMA K, Narita Y, Kadowaki S, Ura T, et al
    Platinum-based Doublet Chemotherapy for Advanced Gastric Cancer with Disseminated Intravascular Coagulation.
    Anticancer Res. 2017;37:309-313.
    PubMed     Text format     Abstract available


  35. JUKIC Z, Radulovic P, Stojkovic R, Mijic A, et al
    Gender Difference in Distribution of Estrogen and Androgen Receptors in Intestinal-type Gastric Cancer.
    Anticancer Res. 2017;37:197-202.
    PubMed     Text format     Abstract available


  36. KOGURE N, Yokobori T, Ogata K, Altan B, et al
    Low Expression of FBXO45 Is Associated with Gastric Cancer Progression and Poor Prognosis.
    Anticancer Res. 2017;37:191-196.
    PubMed     Text format     Abstract available


  37. LEE D, Yu EJ, Ham IH, Hur H, et al
    Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer.
    Anticancer Res. 2017;37:135-142.
    PubMed     Text format     Abstract available


    December 2016
  38. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Efficacy of Nab-Paclitaxel as Second-line Chemotherapy for Unresectable or Recurrent Gastric Cancer.
    Anticancer Res. 2016;36:6699-6703.
    PubMed     Text format     Abstract available


  39. TOIYAMA Y, Shimura T, Yasuda H, Fujikawa H, et al
    Clinical Burden of C-Reactive Protein/Albumin Ratio Before Curative Surgery for Patients with Gastric Cancer.
    Anticancer Res. 2016;36:6491-6498.
    PubMed     Text format     Abstract available


    November 2016
  40. ZHENG LC, Yang MD, Kuo CL, Lin CH, et al
    Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways.
    Anticancer Res. 2016;36:6031-6042.
    PubMed     Text format     Abstract available


  41. HAYASHI N, Kataoka H, Yano S, Kikuchi JI, et al
    Anticancer Effects of a New Aminosugar-conjugated Platinum Complex Agent Against Cisplatin-resistant Gastric Cancer.
    Anticancer Res. 2016;36:6005-6009.
    PubMed     Text format     Abstract available


    October 2016
  42. ARIGAMI T, Uenosono Y, Ishigami S, Yanagita S, et al
    Clinical Impact of Stomach-partitioning Gastrojejunostomy with Braun Enteroenterostomy for Patients with Gastric Outlet Obstruction Caused by Unresectable Gastric Cancer.
    Anticancer Res. 2016;36:5431-5436.
    PubMed     Text format     Abstract available


  43. ALTAN B, Yokobori T, Ide M, Bai T, et al
    High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer.
    Anticancer Res. 2016;36:5237-5247.
    PubMed     Text format     Abstract available


  44. YAWATA K, Osada S, Tanahashi T, Matsui S, et al
    The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.
    Anticancer Res. 2016;36:5215-5226.
    PubMed     Text format     Abstract available


  45. LEMOINE N, Adenis A, Bouche O, Duhamel A, et al
    Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma.
    Anticancer Res. 2016;36:5543-5549.
    PubMed     Text format     Abstract available


  46. KNIEF J, Reddemann K, Petrova E, Herhahn T, et al
    High Density of Tumor-infiltrating B-Lymphocytes and Plasma Cells Signifies Prolonged Overall Survival in Adenocarcinoma of the Esophagogastric Junction.
    Anticancer Res. 2016;36:5339-5345.
    PubMed     Text format     Abstract available


    September 2016
  47. KIM EY, Jun KH, Jung JH, Jo YS, et al
    Laparoscopic Gastrectomy Followed by Chemotherapy for Advanced Gastric Cancer Diagnosed During Pregnancy: A Case Report.
    Anticancer Res. 2016;36:4813-6.
    PubMed     Text format     Abstract available


  48. KIM DJ, Kim W
    Laparoscopy-assisted Proximal Gastrectomy with Double Tract Anastomosis Is Beneficial for Vitamin B12 and Iron Absorption.
    Anticancer Res. 2016;36:4753-8.
    PubMed     Text format     Abstract available


    August 2016
  49. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Improved Efficacy by Addition of Protein-bound Polysaccharide K to Adjuvant Chemotherapy for Advanced Gastric Cancer.
    Anticancer Res. 2016;36:4237-41.
    PubMed     Text format     Abstract available


  50. CHOU NH, Tsai CY, Tu YT, Wang KC, et al
    Isocitrate Dehydrogenase 2 Dysfunction Contributes to 5-hydroxymethylcytosine Depletion in Gastric Cancer Cells.
    Anticancer Res. 2016;36:3983-90.
    PubMed     Text format     Abstract available


  51. ROMAN LD, Lukyanchuk R, Sablin OA, Araslanova EI, et al
    Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel(R)) in St. Petersburg.
    Anticancer Res. 2016;36:4129-38.
    PubMed     Text format     Abstract available


    June 2016
  52. KOMATSU S, Ichikawa D, Kosuga T, Okamoto K, et al
    Clinical Impact of Laparoscopy and Endoscopy Cooperative Surgery (LECS) on Gastric Submucosal Tumor After its Standardization.
    Anticancer Res. 2016;36:3041-7.
    PubMed     Text format     Abstract available


  53. YONENAGA Y, Kurosawa M, Mise M, Yamagishi M, et al
    Pancreatic-type Acinar Cell Carcinoma of the Stomach Included in Multiple Primary Carcinomas.
    Anticancer Res. 2016;36:2855-64.
    PubMed     Text format     Abstract available


    May 2016
  54. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Prognostic Factors for Gastric Cancer with Cancer Cells in the Peritoneal Cavity.
    Anticancer Res. 2016;36:2481-5.
    PubMed     Text format     Abstract available


  55. MURAKAMI T, Zhang Y, Wang X, Hiroshima Y, et al
    Orthotopic Implantation of Intact Tumor Tissue Leads to Metastasis of OCUM-2MD3 Human Gastric Cancer in Nude Mice Visualized in Real Time by Intravital Fluorescence Imaging.
    Anticancer Res. 2016;36:2125-30.
    PubMed     Text format     Abstract available


    April 2016
  56. KIM EY, Choi HJ, Cho JB, Lee J, et al
    Totally Laparoscopic Total Gastrectomy Versus Laparoscopically Assisted Total Gastrectomy for Gastric Cancer.
    Anticancer Res. 2016;36:1999-2003.
    PubMed     Text format     Abstract available


  57. KUCERA R, Smid D, Topolcan O, Karlikova M, et al
    Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics.
    Anticancer Res. 2016;36:1967-71.
    PubMed     Text format     Abstract available


  58. KAWAGUCHI T, Komatsu S, Ichikawa D, Kimura YU, et al
    Prognostic Influence of the Extent of Lymph Node Dissection and Perioperative Comorbidities in Patients with Gastric Cancer.
    Anticancer Res. 2016;36:1917-22.
    PubMed     Text format     Abstract available


  59. OHASHI T, Komatsu S, Ichikawa D, Kosuga T, et al
    Tumor Index as a Combined Indicator of Tumor Depth and Size in Gastric Cancer.
    Anticancer Res. 2016;36:1895-900.
    PubMed     Text format     Abstract available


  60. NAKASHIMA Y, Nakanishi R, Sugiyama M, Ohgaki K, et al
    Laparoscopic Resection of Gastric Cancer in a Patient with Chronic Lymphocytic Leukemia Accompanied by Neutropenia.
    Anticancer Res. 2016;36:1779-83.
    PubMed     Text format     Abstract available


  61. KOSAKA T, Akiyama H, Makino H, Kimura J, et al
    Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
    Anticancer Res. 2016;36:1773-7.
    PubMed     Text format     Abstract available


  62. MAKATSORIS T, Tsamandas AC, Strimpakos A, Alexopoulou Z, et al
    HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.
    Anticancer Res. 2016;36:1581-90.
    PubMed     Text format     Abstract available


  63. TANAKAYA K, Yamaguchi T, Ishikawa H, Hinoi T, et al
    Causes of Cancer Death Among First-Degree Relatives in Japanese Families with Lynch Syndrome.
    Anticancer Res. 2016;36:1985-9.
    PubMed     Text format     Abstract available


    March 2016
  64. SHAO S, Sun PH, Satherley LK, Gao X, et al
    Reduced RanBPM Expression Is Associated with Distant Metastasis in Gastric Cancer and Chemoresistance.
    Anticancer Res. 2016;36:1295-303.
    PubMed     Text format     Abstract available


  65. JIA S, Cai J
    Update on Biomarkers in Development of Anti-angiogenic Drugs in Gastric Cancer.
    Anticancer Res. 2016;36:1111-8.
    PubMed     Text format     Abstract available


  66. SUN J, Ling B, Xu X, Ma R, et al
    Decreased Expression of Tumor-suppressor Gene LKB1 Correlates with Poor Prognosis in Human Gastric Cancer.
    Anticancer Res. 2016;36:869-75.
    PubMed     Text format     Abstract available


  67. ZIMMERMANN N, Lazar-Karsten P, Keck T, Billmann F, et al
    Expression Pattern of CDX2, Estrogen and Progesterone Receptors in Primary Gastroenteropancreatic Neuroendocrine Tumors and Metastases.
    Anticancer Res. 2016;36:921-4.
    PubMed     Text format     Abstract available


    February 2016
  68. KUBO H, Komatsu S, Ichikawa D, Kawaguchi T, et al
    Impact of Body Weight Loss on Recurrence After Curative Gastrectomy for Gastric Cancer.
    Anticancer Res. 2016;36:807-13.
    PubMed     Text format     Abstract available


    January 2016
  69. KURILOVICH S, Belkovets A, Reshetnikov O, Openko T, et al
    Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia.
    Anticancer Res. 2016;36:247-53.
    PubMed     Text format     Abstract available


  70. MIN HL, Kim J, Kim WH, Jang BG, et al
    Epigenetic Silencing of the Putative Tumor Suppressor Gene GLDC (Glycine Dehydrogenase) in Gastric Carcinoma.
    Anticancer Res. 2016;36:179-87.
    PubMed     Text format     Abstract available


  71. MASUDA GO, Yashiro M, Kitayama K, Miki Y, et al
    Clinicopathological Correlations of Autophagy-related Proteins LC3, Beclin 1 and p62 in Gastric Cancer.
    Anticancer Res. 2016;36:129-36.
    PubMed     Text format     Abstract available


    December 2015
  72. MATSUMOTO T, Matsuda D, Honma K, Aoyagi Y, et al
    One-stage Procedure for Concomitant Abdominal Aortic Aneurysm and Gastric Cancer.
    Anticancer Res. 2015;35:6909-12.
    PubMed     Text format     Abstract available


  73. ASO T, Uozaki H, Morita S, Kumagai A, et al
    Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer.
    Anticancer Res. 2015;35:6819-27.
    PubMed     Text format     Abstract available


  74. FUJIWARA Y, Omori T, Demura K, Miyata H, et al
    A Multidisciplinary Approach for Advanced Gastric Cancer with Paraaortic Lymph Node Metastasis.
    Anticancer Res. 2015;35:6739-45.
    PubMed     Text format     Abstract available


  75. SCHMIDT K, Moser C, Hellerbrand C, Zieker D, et al
    Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model.
    Anticancer Res. 2015;35:6655-65.
    PubMed     Text format     Abstract available


  76. OHYAMA M, Tsuchiya A, Kaku Y, Kanno T, et al
    Phosphatidylinositol Derivatives Induce Gastric Cancer Cell Apoptosis by Accumulating AIF and AMID in the Nucleus.
    Anticancer Res. 2015;35:6563-71.
    PubMed     Text format     Abstract available


    November 2015
  77. FUKUCHI M, Ishiguro T, Ogata K, Kimura A, et al
    Risk Factors for Recurrence After Curative Conversion Surgery for Unresectable Gastric Cancer.
    Anticancer Res. 2015;35:6183-7.
    PubMed     Text format     Abstract available


  78. HEINZELMANN S, Bauer G
    Site-specific Effects of DUOX1-Related Peroxidase on Intercellular Apoptosis Signaling.
    Anticancer Res. 2015;35:5955-71.
    PubMed     Text format     Abstract available


  79. POTTGIESSER SJ, Heinzelmann S, Bauer G
    Intercellular HOCl-mediated Apoptosis Induction in Malignant Cells: Interplay Between NOX1-Dependent Superoxide Anion Generation and DUOX-related HOCl-generating Peroxidase Activity.
    Anticancer Res. 2015;35:5927-43.
    PubMed     Text format     Abstract available


    October 2015

  80. Laparoscopic Gastrectomy for Gastric Cancer.
    Anticancer Res. 2015;35:5709.
    PubMed     Text format    


  81. TAMURA T, Ohira M, Tanaka H, Muguruma K, et al
    Programmed Death-1 Ligand-1 (PDL1) Expression Is Associated with the Prognosis of Patients with Stage II/III Gastric Cancer.
    Anticancer Res. 2015;35:5369-76.
    PubMed     Text format     Abstract available


  82. KOSAKA T, Davydova J, Ono HA, Akiyama H, et al
    Imaging and Antitumoral Effect of a Cyclo-oxygenase 2-specific Replicative Adenovirus for Small Metastatic Gastric Cancer Lesions.
    Anticancer Res. 2015;35:5201-10.
    PubMed     Text format     Abstract available


    September 2015
  83. SHOJI H, Yamada Y, Okita N, Takashima A, et al
    Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance.
    Anticancer Res. 2015;35:5055-61.
    PubMed     Text format     Abstract available


  84. JI HX, Chang WS, Tsai CW, Wang JY, et al
    Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotype to Gastric Cancer Risk in Taiwan.
    Anticancer Res. 2015;35:4975-4981.
    PubMed     Text format     Abstract available


  85. YAMAMOTO M, Kawano H, Yamaguchi S, Egashira A, et al
    Comparison of Neoadjuvant Chemotherapy to Surgery Followed by Adjuvant Chemotherapy in Japanese Patients with Peritoneal Lavage Cytology Positive for Gastric Carcinoma.
    Anticancer Res. 2015;35:4859-63.
    PubMed     Text format     Abstract available


  86. SHIMURA T, Toiyama Y, Tanaka K, Saigusa S, et al
    Angiopoietin-like Protein 2 as a Predictor of Early Recurrence in Patients After Curative Surgery for Gastric Cancer.
    Anticancer Res. 2015;35:4633-9.
    PubMed     Text format     Abstract available


  87. NUKATSUKA M, Nakagawa F, Takechi T
    Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
    Anticancer Res. 2015;35:4605-15.
    PubMed     Text format     Abstract available


  88. CHROM P, Stec R, Szczylik C
    Second-line Treatment of Advanced Gastric Cancer: Current Options and Future Perspectives.
    Anticancer Res. 2015;35:4575-83.
    PubMed     Text format     Abstract available


    July 2015
  89. TOYOKAWA T, Ohira M, Sakurai K, Kubo N, et al
    The Role of Adjuvant Chemotherapy for Patients with Stage IB Gastric Cancer.
    Anticancer Res. 2015;35:4091-7.
    PubMed     Text format     Abstract available


  90. KIM SH, Lee OJ, Kwon JL, Kim JM, et al
    Altered Expression of Yes-associated Protein and beta-Catenin in Non-neoplastic and Neoplastic Gastric Surface Epithelia.
    Anticancer Res. 2015;35:3925-31.
    PubMed     Text format     Abstract available


  91. JERNMAN J, Hagstrom J, Maenpaa H, Valimaki MJ, et al
    Expression of Stem Cell-associated Marker HES77 in Rectal Neuroendocrine Tumors.
    Anticancer Res. 2015;35:3767-72.
    PubMed     Text format     Abstract available


    June 2015
  92. SHIDA A, Futawatari N, Fukuyama T, Ichiki Y, et al
    Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.
    Anticancer Res. 2015;35:3575-9.
    PubMed     Text format     Abstract available


  93. KIM JY, Ryoo HM, Bae SH, Kang BW, et al
    Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer.
    Anticancer Res. 2015;35:3531-6.
    PubMed     Text format     Abstract available


  94. OHI M, Mori K, Toiyama Y, Mohri Y, et al
    Preoperative prediction of peritoneal metastasis in gastric cancer as an indicator for neoadjuvant treatment.
    Anticancer Res. 2015;35:3511-8.
    PubMed     Text format     Abstract available


  95. KIM HS, Lee HS, Nam KH, Choi J, et al
    Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
    Anticancer Res. 2015;35:3501-10.
    PubMed     Text format     Abstract available


    May 2015
  96. KATSUBE T, Murayama M, Yamaguchi K, Usuda A, et al
    Additional Surgery After Non-curative Resection of ESD for Early Gastric Cancer.
    Anticancer Res. 2015;35:2969-74.
    PubMed     Text format     Abstract available


  97. CACINA C, Arikan S, Duzkoylu Y, Dogan MB, et al
    Analyses of EGF A61G Gene Variation and Serum EGF Level on Gastric Cancer Susceptibility and Clinicopathological Parameters.
    Anticancer Res. 2015;35:2709-13.
    PubMed     Text format     Abstract available


  98. CHOI B, Lee EJ, Park YS, Kim SM, et al
    Pentraxin-3 Silencing Suppresses Gastric Cancer-related Inflammation by Inhibiting Chemotactic Migration of Macrophages.
    Anticancer Res. 2015;35:2663-8.
    PubMed     Text format     Abstract available


    April 2015
  99. VIEIRA PC, Burbano RM, Fernandes DC, Montenegro RC, et al
    Population stratification effect on cancer susceptibility in an admixed population from Brazilian Amazon.
    Anticancer Res. 2015;35:2009-14.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: